Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status

Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status

US Patent 11808772 · Granted Nov 7, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
Combination treponemal and non-treponemal syphilis test2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025
Combination treponemal and non-treponemal syphilis test2024
Immunoassay for SARS-CoV-2 neutralizing antibodies and materials therefor2023
Lipoxin and lipoxin analogue mediated neuroprotection and treatments2022
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2022
Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms2022
Method to predict response to pharmacological chaperone treatment of diseases2021
Combination treponemal and non-treponemal syphilis test2021
Recombinant deamidated gliadin antigen2021
Method to predict response to pharmacological chaperone treatment of diseases2020